Daniella Kranjac

Founding Partner • Dynamk Capital

Daniella Kranjac is Founding Partner at Dynamk Capital, uniquely focused on Life Science Industrials – the tools, technologies and services that enable the discovery, development and production of life-saving therapies and deliver on the biopharmaceutical industry’s evolution towards lower costs, and increased access to medicines globally. 

Daniella currently serves on the boards of Envisagenics, RoosterBio, Virica Biotech and Xcell Biosciences.  She previously served on the boards of FloDesign Sonics (acquired by Millipore Sigma) and Stevens Institute of Technology, where she was a Trustee. Prior to Dynamk Capital, she was CEO and Founder of Dynamk Consulting, providing strategy and business development consulting to leading life science companies and startups

Also Speaking

Stuart Gibb

Scientific Strategy Lead • Terumo Blood and Cell Technologies

Stefano Baila

Managing Director • Eurofins

Dave Lennon

Chief Executive Officer • Satellite Bio

Also Speaking


Post-Event Report

Download the post-event report for Advanced Therapies Week 2024.

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.